The Impact of Oral Ethanol and Vaped Ethanol on the Evaluation of Impairment
NCT ID: NCT04522973
Last Updated: 2026-01-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2023-04-21
2024-07-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
NCT02580318
Reactions to E-cigs and Alcohol
NCT03449017
Substrate Metabolism During Exercise Following Ingestion of Ethanol
NCT03404947
The Effect of Alcoholic-carrier Solutions Within Devices (HFA134a-MDI or Respimat®) on Breath Alcohol Measured by Ethylometer in Healthy Volunteers
NCT02264145
Alcohol Based Hand Sanitizer: Can Frequent Use Cause an Elevated Blood Alcohol Level?
NCT00297908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Within group four condition comparison
Participants completed four \~5-hour, Latin-square ordered sessions separated by ≥48 hours. Session order was not recorded as it was not relevant to the study outcomes: Beverage with ethanol and E-cigarette liquid with ethanol, Beverage with ethanol and E-cigarette liquid without ethanol, Beverage without ethanol and E-cigarette liquid with ethanol, and Beverage without ethanol and E-cigarette liquid without ethanol.
Beverage with ethanol and E-cigarette liquid with ethanol
Beverage with ethanol and E-cigarette liquid with ethanol
Beverage with ethanol and E-cigarette liquid without ethanol
Beverage with ethanol and E-cigarette liquid without ethanol
Beverage without ethanol and E-cigarette liquid with ethanol
Beverage without ethanol and E-cigarette liquid with ethanol
Beverage without ethanol and E-cigarette liquid without ethanol
Beverage without ethanol and E-cigarette liquid without ethanol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beverage with ethanol and E-cigarette liquid with ethanol
Beverage with ethanol and E-cigarette liquid with ethanol
Beverage with ethanol and E-cigarette liquid without ethanol
Beverage with ethanol and E-cigarette liquid without ethanol
Beverage without ethanol and E-cigarette liquid with ethanol
Beverage without ethanol and E-cigarette liquid with ethanol
Beverage without ethanol and E-cigarette liquid without ethanol
Beverage without ethanol and E-cigarette liquid without ethanol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* alcohol consumers
* willing to provide informed consent
* able to attend the lab sessions as needed
* agree to use designated products according to study protocol.
Exclusion Criteria
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. Department of Justice
FED
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alison Breland, PhD
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-MU-MU-0007
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
HM20018402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.